Dear Colleague Letter: Xylazine

Communicating for Impact
Written by Jalyn Burns

The DEA recently issued a warning about xylazine, a veterinary drug. This "Dear Colleague" letter from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a report on the risks of xylazine.

Learn more

Source: Substance Abuse and Mental Health Services Administration (SAMHSA)

Jalyn Burns
Previous

Harm Reduction Hacks Microsite
Next

Fact Sheet: California Law and Syringe Services Programs